Clinical Trials for Epigenetix

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Epigenetix

Clinical Trials (1)

NCT05488548
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
PHASE1Recruiting
75 participants
Started: Dec 21, 2022 · Completed: May 31, 2025
4 conditions1 sponsor6 locations